Epidemiological survey of Clostridium difficile ribotypes in the North East of England during an 18-month period

Journal of Hospital Infection

Volumn 81, Issue 3, 2012, Pages 209-212

  Vanek, J ^a   Hill, K ^b   Collins, J ^b   Berrington, A ^c   Perry, J ^b   Inns, T ^d   Gorton, R ^d   Magee, J ^d   Sails, A ^d   Mullan, A ^e   Gould, F K ^b  

^a ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

^b FREEMAN HOSPITAL   (United Kingdom)

^c CITY HOSPITALS SUNDERLAND NHS FOUNDATION TRUST   (United Kingdom)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e NONE   (United Kingdom)

Author keywords

Clostridium difficile infection; Ribotypes

Indexed keywords

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM COLONY; BACTERIUM CULTURE; BACTERIUM ISOLATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; FECES ANALYSIS; NONHUMAN; POLYMERASE CHAIN REACTION; RIBOTYPING; UNITED KINGDOM;

AGED; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; ENGLAND; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FEMALE; HUMANS; MALE; POLYMERASE CHAIN REACTION; RIBOTYPING;

EID: 84862651859     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2012.04.017     Document Type: Article

References (10)

1. Ghantoji S.S., Sail K., Lairson D.R., Dupont H.L., Garey K.W. Economic healthcare costs of Clostridium difficile infection: a systematic review. J Hosp Infect 2010, 74:309-318.
2. Bidet P., Laland V., Salauze B., et al. Comparison of PCR-ribotyping, arbitrary primed PCR, and pulsed-field gel electrophoresis for typing Clostridium difficile. J Clin Microbiol 2000, 38:2484-2487.
3. Killgore G., Thompson A., Johnson S., et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile. J Clin Microbiol 2008, 46:431-437.
4. Iwashima Y., Nakamura A., Kato H., et al. A retrospective study of the epidemiology of Clostridium difficile infection at a University Hospital in Japan: genotypic features of the isolates and clinical characteristics of the patients. J Infect Chemother 2010, 16:329-333.
5. National Clostridium difficile Standards Group. Report to the Department of Health. J Hosp Infect 2004, 56(Suppl. 1).
6. Health Protection Agency Toxin detection, isolation and identification of Clostridium difficile from faeces. National standard method BSOP 10 2007, HPA, London.
7. Stubbs S.L.J., Brazier J.S., O'Neill G.L., Duerden B.I. PCR targeted to the 16S-23S rRNA GENE intergenic spacer region of Clostridium difficile and construction of a library consisting of 116 different PCR ribotypes. J Clin Microbiol 1999, 37:461-463.
8. Ribotyping Network (CDRN) for England and Northern Ireland 2009/10 Report 2010, HPA, London.
9. Bartlett J.G., Gerding D.N. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008, 46:S12-S18.
10. Chand M.A., Fleming M.J., Wellsteed S., Kelsey M.C. Impact of changes in Clostridium difficile diagnostic testing on detection of C. difficile infection and all England mandatory surveillance data. J Hosp Infect 2011, 79:8-12.